Skanska has signed a contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA.
STOCKHOLM, Sept. 30, 2022 /PRNewswire/ -- Skanska has signed a contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA. The contract is worth USD 58M, about SEK 570M, which will be included in the US order bookings for the third quarter 2022.
The five-story building on the Cooperman Barnabas Medical Center campus, totaling 13,000 gross square meters, is designed to support patients’ care and wellbeing. The new facility will provide outpatient cancer treatment, including four new linear accelerators and a high-dose MRI unit. A parking garage will also be constructed.
Construction started September 2022, and completion is scheduled for July 2025.
For further information please contact:
Mia Walton, VP Communications, Skanska USA Building, tel + 1 (240) 672 17 89
Jacob Birkeland, Head of Media Relations and Public Affairs, Skanska AB, tel: +46 (0)10 449 19 57
Direct line for media, tel +46 (0)10 448 88 99
This and previous releases can also be found at www.skanska.com.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
| 20220930 US Cancer Center |
View original content:https://www.prnewswire.com/news-releases/skanska-builds-ambulatory-care-cancer-center-in-livingston-new-jersey-usa-for-usd-58m-about-sek-570m-301637528.html
SOURCE Skanska
Company Codes: Bloomberg:SKAB@SS, ISIN:SE0000113250, RICS:SKAB.ST, Stockholm:SKA.B
